High doses of 3-PO, a small molecule inhibitor of PFKFB3, can inhibit proliferation of cancer cells and reduce the growth of primary tumors, whereas a low dose of 3-PO induced tumor vascular barrier tightening and maturation, reducing cancer cell intravasation and metastasis [166]. Here, PFKFB3 is linked to cancer.